Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Meroni

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Journal of Translational Autoimmunity|April 5, 2021
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseasesEléonore Bettacchioli, Christelle Le Gaffric, Margaux Mazeas, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2003
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune diseasePaola Bossù, Detlef Neumann, Elda Del Giudice, et al.
The Journal of Rheumatology|December 1, 2004
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupusPatrick Gordon, Munther A Khamashta, Eric Rosenthal, et al.
Clinical Chemistry and Laboratory Medicine|May 29, 2015
Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testingJuliane Scholz, Kai Grossmann, Ilka Knütter, et al.
Journal of Clinical Medicine|June 10, 2023
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 PatientsRoberta Gualtierotti, Sharon E Fox, Fernanda Da Silva Lameira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolismNicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
The Journal of Pathology. Clinical Research|April 7, 2018
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progressionHege L Pedersen, Kjersti D Horvei, Dhivya Thiyagarajan, et al.
Plos One|September 17, 2014
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCAMandy Sowa, Kai Grossmann, Ilka Knütter, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Journal of Translational Autoimmunity|April 5, 2021
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseasesEléonore Bettacchioli, Christelle Le Gaffric, Margaux Mazeas, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2003
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune diseasePaola Bossù, Detlef Neumann, Elda Del Giudice, et al.
The Journal of Rheumatology|December 1, 2004
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupusPatrick Gordon, Munther A Khamashta, Eric Rosenthal, et al.
Clinical Chemistry and Laboratory Medicine|May 29, 2015
Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testingJuliane Scholz, Kai Grossmann, Ilka Knütter, et al.
Journal of Clinical Medicine|June 10, 2023
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 PatientsRoberta Gualtierotti, Sharon E Fox, Fernanda Da Silva Lameira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolismNicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
The Journal of Pathology. Clinical Research|April 7, 2018
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progressionHege L Pedersen, Kjersti D Horvei, Dhivya Thiyagarajan, et al.
Plos One|September 17, 2014
Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCAMandy Sowa, Kai Grossmann, Ilka Knütter, et al.
Pageof 28